Dynavax Technologies Corporation
DVAX
$10.31
-$0.34-3.19%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -10.45% | 13.05% | |||
| Total Other Revenue | -23.81% | -64.37% | |||
| Total Revenue | -10.66% | 9.26% | |||
| Cost of Revenue | 16.96% | 2.07% | |||
| Gross Profit | -24.43% | 13.24% | |||
| SG&A Expenses | -3.45% | 3.51% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.56% | 2.94% | |||
| Operating Income | -95.33% | 65.97% | |||
| Income Before Tax | -61.50% | 32.95% | |||
| Income Tax Expenses | -73.97% | -36.82% | |||
| Earnings from Continuing Operations | -59.93% | 54.52% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -59.93% | 54.52% | |||
| EBIT | -95.33% | 65.97% | |||
| EBITDA | -86.95% | 57.78% | |||
| EPS Basic | -58.94% | 54.25% | |||
| Normalized Basic EPS | -60.53% | 32.72% | |||
| EPS Diluted | -64.48% | 48.66% | |||
| Normalized Diluted EPS | -61.00% | 32.67% | |||
| Average Basic Shares Outstanding | -2.43% | 0.17% | |||
| Average Diluted Shares Outstanding | -1.15% | 0.22% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||